...
首页> 外文期刊>European Journal of Histochemistry >IncRNA MAPKAPK5-AS1 promotes proliferation and migration of thyroid cancer cell lines by targeting miR-519e-5p/YWHAH
【24h】

IncRNA MAPKAPK5-AS1 promotes proliferation and migration of thyroid cancer cell lines by targeting miR-519e-5p/YWHAH

机译:Incrna mapkapk5-AS1通过靶向MIR-519E-5P / YWHAH来促进甲状腺癌细胞系的增殖和迁移

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Thyroid cancer is a common malignant tumour of the endocrine system and ranks ninth in cancer incidence worldwide. An extensive body of evidence has demonstrated that lncRNAs play a critical role in the progression of thyroid cancer. The lncRNA MAPKAPK5-AS1 has been reported to be abnormally expressed and to play a role in the development of various human cancers. However, MAPKAPK5-AS1’s potential role in thyroid cancer progression remains unknown. The objective of our study was to explore the role and mechanism of MAPKAPK5-AS1 in thyroid cancer cells and provide a potential target for its biological diagnosis and treatment. We transfected sh-MAPKAPK5-AS1 and sh-NC into BCPAP and TPC-1 cells for loss-of-function assays. Results of RT-qPCR analysis demonstrated that MAPKAPK5-AS1 was more highly expressed in thyroid cancer cells compared to normal cells. Functional assays demonstrated that interfering with the expression of MAPKAPK5-AS1 notably repressed proliferation and invasion and accelerated apoptosis of BCPAP and TPC-1 cells. Mechanistically, we found that miR-519e-5p was negatively regulated by MAPKAPK5-AS1 and that tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta (YWHAH) was a target of miR-519e-5p. Additionally, rescue assays demonstrated that downregulation of MAPKAPK5-AS1 expression inhibited cell proliferation, migration, and invasion and promoted apoptosis by sponging miR-519e-5p, thereby increasing YWHAH expression. Ultimately, our study revealed that MAPKAPK5-AS1 promotes proliferation and migration of thyroid cancer cells by targeting the miR-519e-5p/YWHAH axis, which provides novel insight into the development and progression of thyroid cancer.
机译:甲状腺癌是内分泌系统的常见恶性肿瘤,并在全世界癌症发病率排名第九。广泛的证据表明,LNCRNA在甲状腺癌的进展中发挥着关键作用。据报道,LNCRNA Mapkapk5-AS1异常表达,并在各种人类癌症的发展中发挥作用。然而,Mapkapk5-AS1在甲状腺癌进展中的潜在作用仍然未知。我们研究的目的是探讨Mapkapk5-AS1在甲状腺癌细胞中的作用和机制,并为其生物诊断和治疗提供潜在的目标。我们将Sh-Mapkapk5-AS1和SH-NC转染到BCPAP和TPC-1细胞中,以进行函数丧失测定。 RT-QPCR分析结果表明,与正常细胞相比,MapKapk5-AS1在甲状腺癌细胞中更高度表达。功能测定证明,干扰MapKapk5-AS1的表达,特别是抑制增殖和侵袭和加速BCPAP和TPC-1细胞的凋亡。机械地,我们发现MAPKAPK5-AS1负调节miR-519E-5P,酪氨酸3-单氧基酶/色氨酸5-单氧化酶活化蛋白ETA(YWHAH)是miR-519E-5P的靶标。另外,救援测定证明,MapKAPK5-AS1表达的下调抑制细胞增殖,迁移和侵袭,并通过冲水MIR-519E-5P促进细胞凋亡,从而增加Ywhah表达。最终,我们的研究表明,MapKapk5-AS1通过靶向MIR-519E-5P / YWHAH轴来促进甲状腺癌细胞的增殖和迁移,这为甲状腺癌的发育和进展提供了新的洞察力。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号